Skip To Main Content

The Vaccination

Information about supplied vaccines, effectiveness and the vaccination rollouts

Characteristics of COVID-19 Vaccines

COVID-19 vaccines are effective in preventing severe illness and symptoms such as fever or coughs. Vaccination is expected to reduce the number of severe COVID-19 patients and deaths.
Some cases of side effects such as localized pain in the injected site, headache, fatigue, muscle and joint pain, and anaphylaxis (acute allergic reaction) after vaccination in some rare cases have been reported.
Through their pharmaceutical approvals, effectiveness and safety of vaccines for COVID-19 has been verified based on clinical trials and scientific findings.

Available Vaccines

Vaccines available in Japan are currently from Pfizer and Moderna.

Pfizer Inc.
Vaccine name: Comirnaty
Pharmaceutical approval: February 14, 2021
Vaccine type: mRNA vaccine  Number of times to administer: twice  Vaccination interval: 21 days
Click hereOpen in a new window for details of the vaccine
Takeda Pharmaceutical Company Limited/Moderna Inc.
Vaccine name: Moderna COVID-19 vaccine
Pharmaceutical approval: May 21, 2021
Vaccine type: mRNA vaccine  Number of times to administer: twice  Vaccination interval: 28 days
Click hereOpen in a new window for details of the vaccine

Vaccination rollouts in Japan (by prefecture)

Please refer to hereOpen in a new window.

Novel Coronavirus Vaccination Q&A Website

We answer the questions about the effectiveness of the novel coronavirus vaccines, their safety, and your eligibility.